Consolidated Statements of Operations and Comprehensive Income (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended		87 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
Revenues	$ 35		$ 35
Cost of sales	382		382
Gross margin	(347)		(347)
Costs and expenses
Research and development	2,916	3,367	15,854
Selling, general and administrative	3,392	2,306	12,387
Total costs and expenses	6,308	5,673	28,241
Loss from operations	(6,655)	(5,673)	(28,588)
Other income and (expense)
Other income			1,147
Interest income			79
Amortization of deferred financing costs	(14)	(37)	(1,984)
Interest expense	(55)	(48)	(167)
Total other income and (expense)	(69)	(85)	(925)
Loss before income tax	(6,724)	(5,758)	(29,513)
Provision for income tax
Net loss	(6,724)	(5,758)	(29,513)
Comprehensive income (Loss)
Comprehensive loss	(6,724)	(5,758)	(29,513)
Loss attributable to common stockholders and loss per common share:
Net loss	(6,724)	(5,758)	(29,513)
Loss attributable to common stockholders	(6,724)	(5,758)	(34,880)
Weighted average shares outstanding, basic and diluted	46,218	28,004
Net loss per basic and diluted share	$ (0.15)	$ (0.21)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend			(4,301)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend			(700)
Declared/Accrued Dividends - Series A Preferred Stock			$ (366)